International relationsETPN establishes strong collaborations with international partners in Nanomedicine
EU – US Nanomedicine Community of Research (CoR)
The U.S.-EU Nanotechnology Communities of Research (CORs) provide a platform for scientists to collaboratively identify and address key research needs through community-led activities such as telecons, webinars, publications, and annual in-person meetings. There are currently seven CORs addressing questions about the potential environmental, health, and safety (EHS) implications of nanomaterials and one Nanomedicine COR.
The Nanomedicine CoR (visit the official website) was launched in September 2018 and is co-chaired for the US by Anil Patri – Director of core facility on Nanotechnology at FDA , and for EU by Patrick Boisseau – Chairman of the ETPN.
Accelerated development of nanotechnology based innovative therapeutic and diagnostic products is needed to benefit patients across the globe.
How does it work?
- Who: Stakeholders from academia, government, industry, and NGOs in the U.S., EU, and third-party countries interested in nanomedicine.
- What: A platform for scientists to develop a shared repertoire of protocols, methods and lessons learned to overcome research and knowledge gaps to increase the success rate for clinical translation
- Where: Video- and/or teleconferences and annual workshops
- Why: To address health and safety concerns about on nanomaterials for medical applications and to collaboratively advance the field
- How: The communities will be largely self-run with the ETPN coordinating the participation of EU stakeholders and the U.S. National Nanotechnology Coordination Office providing administrative support.
If you wish to receive more information about the US-EU Nanomedicine CoR